Selected research
Industry Research
Blonanserin Tablets Industry Research Report 2026
Market perspective
The global Blonanserin Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blonanserin Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blonanserin Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blonanserin Tablets include Intas, Lifecare Neuro Products, Recipharm, Sumitomo Pharma, Taj Life Sciences, LIVZON PHARMACEUTICAL, Shijiazhuang No.4 Pharmaceutical and Xiangzhong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blonanserin Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blonanserin Tablets Market by Company
Intas
Lifecare Neuro Products
Recipharm
Sumitomo Pharma
Taj Life Sciences
LIVZON PHARMACEUTICAL
Shijiazhuang No.4 Pharmaceutical
Xiangzhong Pharmaceutical
Blonanserin Tablets Segment by Type
4mg
8mg
Blonanserin Tablets Segment by Application
Adults
Children
Blonanserin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blonanserin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blonanserin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blonanserin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blonanserin Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blonanserin Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blonanserin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Adults
- Children
Companies covered
- Intas
- Lifecare Neuro Products
- Recipharm
- Sumitomo Pharma
- Taj Life Sciences
- LIVZON PHARMACEUTICAL
- Shijiazhuang No.4 Pharmaceutical
- Xiangzhong Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blonanserin Tablets Market Size (2021-2032)
- 2.2.2 Global Blonanserin Tablets Sales (2021-2032)
- 2.2.3 Global Blonanserin Tablets Market Average Price (2021-2032)
- 2.3 Blonanserin Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 4mg
- 2.3.3 8mg
- 2.4 Blonanserin Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blonanserin Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blonanserin Tablets Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Blonanserin Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Blonanserin Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Blonanserin Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blonanserin Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blonanserin Tablets, Product Type & Application
- 3.8 Global Manufacturers of Blonanserin Tablets, Established Date
- 3.9 Global Blonanserin Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Intas
- 4.1.1 Intas Company Information
- 4.1.2 Intas Business Overview
- 4.1.3 Intas Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Intas Blonanserin Tablets Product Portfolio
- 4.1.5 Intas Recent Developments
- 4.2 Lifecare Neuro Products
- 4.2.1 Lifecare Neuro Products Company Information
- 4.2.2 Lifecare Neuro Products Business Overview
- 4.2.3 Lifecare Neuro Products Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lifecare Neuro Products Blonanserin Tablets Product Portfolio
- 4.2.5 Lifecare Neuro Products Recent Developments
- 4.3 Recipharm
- 4.3.1 Recipharm Company Information
- 4.3.2 Recipharm Business Overview
- 4.3.3 Recipharm Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Recipharm Blonanserin Tablets Product Portfolio
- 4.3.5 Recipharm Recent Developments
- 4.4 Sumitomo Pharma
- 4.4.1 Sumitomo Pharma Company Information
- 4.4.2 Sumitomo Pharma Business Overview
- 4.4.3 Sumitomo Pharma Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sumitomo Pharma Blonanserin Tablets Product Portfolio
- 4.4.5 Sumitomo Pharma Recent Developments
- 4.5 Taj Life Sciences
- 4.5.1 Taj Life Sciences Company Information
- 4.5.2 Taj Life Sciences Business Overview
- 4.5.3 Taj Life Sciences Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Life Sciences Blonanserin Tablets Product Portfolio
- 4.5.5 Taj Life Sciences Recent Developments
- 4.6 LIVZON PHARMACEUTICAL
- 4.6.1 LIVZON PHARMACEUTICAL Company Information
- 4.6.2 LIVZON PHARMACEUTICAL Business Overview
- 4.6.3 LIVZON PHARMACEUTICAL Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LIVZON PHARMACEUTICAL Blonanserin Tablets Product Portfolio
- 4.6.5 LIVZON PHARMACEUTICAL Recent Developments
- 4.7 Shijiazhuang No.4 Pharmaceutical
- 4.7.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 4.7.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 4.7.3 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product Portfolio
- 4.7.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 4.8 Xiangzhong Pharmaceutical
- 4.8.1 Xiangzhong Pharmaceutical Company Information
- 4.8.2 Xiangzhong Pharmaceutical Business Overview
- 4.8.3 Xiangzhong Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Xiangzhong Pharmaceutical Blonanserin Tablets Product Portfolio
- 4.8.5 Xiangzhong Pharmaceutical Recent Developments
5 Global Blonanserin Tablets Market Scenario by Region
- 5.1 Global Blonanserin Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blonanserin Tablets Sales by Region: 2021-2032
- 5.2.1 Global Blonanserin Tablets Sales by Region: 2021-2026
- 5.2.2 Global Blonanserin Tablets Sales by Region: 2027-2032
- 5.3 Global Blonanserin Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Blonanserin Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Blonanserin Tablets Revenue by Region: 2027-2032
- 5.4 North America Blonanserin Tablets Market Facts & Figures by Country
- 5.4.1 North America Blonanserin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blonanserin Tablets Sales by Country (2021-2032)
- 5.4.3 North America Blonanserin Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blonanserin Tablets Market Facts & Figures by Country
- 5.5.1 Europe Blonanserin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blonanserin Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Blonanserin Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blonanserin Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blonanserin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blonanserin Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blonanserin Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blonanserin Tablets Market Facts & Figures by Country
- 5.7.1 South America Blonanserin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blonanserin Tablets Sales by Country (2021-2032)
- 5.7.3 South America Blonanserin Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blonanserin Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blonanserin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blonanserin Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blonanserin Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blonanserin Tablets Sales by Type (2021-2032)
- 6.1.1 Global Blonanserin Tablets Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Blonanserin Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Blonanserin Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Blonanserin Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blonanserin Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Blonanserin Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blonanserin Tablets Sales by Application (2021-2032)
- 7.1.1 Global Blonanserin Tablets Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Blonanserin Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Blonanserin Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Blonanserin Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blonanserin Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Blonanserin Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blonanserin Tablets Value Chain Analysis
- 8.1.1 Blonanserin Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blonanserin Tablets Production Mode & Process
- 8.2 Blonanserin Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blonanserin Tablets Distributors
- 8.2.3 Blonanserin Tablets Customers
9 Global Blonanserin Tablets Analyzing Market Dynamics
- 9.1 Blonanserin Tablets Industry Trends
- 9.2 Blonanserin Tablets Industry Drivers
- 9.3 Blonanserin Tablets Industry Opportunities and Challenges
- 9.4 Blonanserin Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst